secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nurix Therapeutics, Inc. (NRIX)
CIK:        0001549595
Form:       8-K
Filed at:   2021-09-30T23:59:59+00:00
Accession:  0001193125-21-287318
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nurix Therapeutics names Judith Reinsdorf and Paul Silva to board, effective Oct 1
--------------------------------------------------------------------------------

- Judith Reinsdorf appointed to board and Governance Committee; Paul Silva to Audit Committee.
- Each receives initial option to purchase 35,000 shares vesting over three years.
- Reinsdorf is former EVP & GC of Johnson Controls; Silva is former SVP & CAO of Vertex.
- Appointments effective Oct 1, 2021; both also receive pro-rata cash retainers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549595/000119312521287318/0001193125-21-287318-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549595/000119312521287318/d225615d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-287318

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer